Company Ticker News November 9, 2021Aprea Therapeutics Reports Third Quarter 2021 Financial Results and Provides Update on Business Operations 0 0 Share
Company Ticker News November 5, 2021Aprea Therapeutics to Present Data from Clinical Trials Evaluating Eprenetapopt at 63rd American Society of Hematology Annual Meeting 0 0 Share
Press Release September 21, 2021Aprea Therapeutics Presents Data From Phase 1/2 Trial of Eprenetapopt (APR-246) in Advanced Solid Tumors at ESMO Congress 2021 0 0 Share
Press Release September 20, 2021Is the Options Market Predicting a Spike in Aprea Therapeutics (APRE) Stock? 0 0 Share
Company Ticker News September 19, 2021Best Penny Stocks To Buy? 5 To Watch This Week With Biotech Catalysts 0 0 Share
Company Ticker News August 13, 2021Aprea Therapeutics Reports Second Quarter 2021 Financial Results and Provides Update on Business Operations 0 0 Share
Press Release August 12, 2021Aprea Therapeutics Announces Clinical Hold on Lymphoid Malignancy Program 0 0 Share
Press Release August 12, 2021Aprea Therapeutics Drops After FDA Clinical Hold On Another Blood Cancer Study 0 0 Share
Company Ticker News August 6, 2021Aprea Therapeutics Stock Drops On FDA Clinical Hold On Eprenetapopt Myeloid Malignancy Trials 0 0 Share
